Search research articles
Contact Us
Filters
Showing results (1-10 of 35) with videos related to
Page
of 4
Sort By:
Urologic Oncology
|
April 1, 2014
Commentary on "Postoperative radiotherapy after radical prostatectomy for high-risk prostate cancer: long-term results of a randomised controlled trial (EORTC trial 22911)." Bolla M, van Poppel H, Tombal B, Vekemans K, Da Pozzo L, de Reijke TM, Verbaeys A, Bosset JF, van Velthoven R, Colombel M, van de Beek C, Verhagen P, van den Bergh A, Sternberg C, Gasser T, van Tienhoven G, Scalliet P, Haustermans K, Collette L; European Organisation for Research and Treatment of Cancer, Radiation Oncology and Genito-Urinary Groups. Department of Radiation Oncology, Centre Hospitalier Universitaire A Michallon, Grenoble, France.: Lancet 2012;380(9858):2018-27. doi: 10.1016/S0140-6736(12)61253-7. [Epub 2012 Oct 19]
Mark A Ritter
Urologic Oncology
|
January 22, 2014
Commentary on "initial management of prostate-specific antigen-detected, low-risk prostate cancer and the risk of death from prostate cancer." Aizer AA, Chen MH, Hattangadi J, D'Amico AV. Harvard Radiation Oncology program, Boston, MA.: BJU Int 2013. doi: 10.1111/j.1464-410X.2012.11789.x. [Epub ahead of print]
Mark A Ritter
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
July 2, 2005
The alpha/beta ratio for prostate cancer: what is it, really?
Søren M Bentzen, Mark A Ritter
International Journal of Radiation Oncology, Biology, Physics
|
December 31, 2002
Optimal stochastic correction strategies for rigid-body target motion
Harry Keller, Mark A Ritter, T Rock Mackie
Seminars in Radiation Oncology
|
December 28, 2005
Platinum-based concurrent chemoradiotherapy for tumors of the head and neck and the esophagus
Desirée Hao, Mark A Ritter, Tom Oliver, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 28, 2003
What hypofractionated protocols should be tested for prostate cancer?
Jack F Fowler, Mark A Ritter, Rick J Chappell, et al.
Cancer
|
August 10, 2007
Management of prostate cancer recurrences after radiation therapy-brachytherapy as a salvage option
Gregory W Allen, Andrew R Howard, David F Jarrard, et al.
Seminars in Radiation Oncology
|
January 10, 2003
Clinical promise tempered by reality in the delivery of combined chemoradiation for common solid tumors
Paul M Harari, Minesh P Mehta, Mark A Ritter, et al.
Urologic Oncology
|
October 20, 2018
Semen AMACR protein as a novel method for detecting prostate cancer
Tyler Etheridge, Jane Straus, Mark A Ritter, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
July 17, 2003
Rectal dose sparing with a balloon catheter and ultrasound localization in conformal radiation therapy for prostate cancer
Rakesh R Patel, Nigel Orton, Wolfgang A Tomé, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 35) with videos related to
Sort By:
Page
of 4
Urologic Oncology
|
April 1, 2014
Commentary on "Postoperative radiotherapy after radical prostatectomy for high-risk prostate cancer: long-term results of a randomised controlled trial (EORTC trial 22911)." Bolla M, van Poppel H, Tombal B, Vekemans K, Da Pozzo L, de Reijke TM, Verbaeys A, Bosset JF, van Velthoven R, Colombel M, van de Beek C, Verhagen P, van den Bergh A, Sternberg C, Gasser T, van Tienhoven G, Scalliet P, Haustermans K, Collette L; European Organisation for Research and Treatment of Cancer, Radiation Oncology and Genito-Urinary Groups. Department of Radiation Oncology, Centre Hospitalier Universitaire A Michallon, Grenoble, France.: Lancet 2012;380(9858):2018-27. doi: 10.1016/S0140-6736(12)61253-7. [Epub 2012 Oct 19]
Mark A Ritter
Urologic Oncology
|
January 22, 2014
Commentary on "initial management of prostate-specific antigen-detected, low-risk prostate cancer and the risk of death from prostate cancer." Aizer AA, Chen MH, Hattangadi J, D'Amico AV. Harvard Radiation Oncology program, Boston, MA.: BJU Int 2013. doi: 10.1111/j.1464-410X.2012.11789.x. [Epub ahead of print]
Mark A Ritter
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
July 2, 2005
The alpha/beta ratio for prostate cancer: what is it, really?
Søren M Bentzen, Mark A Ritter
International Journal of Radiation Oncology, Biology, Physics
|
December 31, 2002
Optimal stochastic correction strategies for rigid-body target motion
Harry Keller, Mark A Ritter, T Rock Mackie
Seminars in Radiation Oncology
|
December 28, 2005
Platinum-based concurrent chemoradiotherapy for tumors of the head and neck and the esophagus
Desirée Hao, Mark A Ritter, Tom Oliver, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 28, 2003
What hypofractionated protocols should be tested for prostate cancer?
Jack F Fowler, Mark A Ritter, Rick J Chappell, et al.
Cancer
|
August 10, 2007
Management of prostate cancer recurrences after radiation therapy-brachytherapy as a salvage option
Gregory W Allen, Andrew R Howard, David F Jarrard, et al.
Seminars in Radiation Oncology
|
January 10, 2003
Clinical promise tempered by reality in the delivery of combined chemoradiation for common solid tumors
Paul M Harari, Minesh P Mehta, Mark A Ritter, et al.
Urologic Oncology
|
October 20, 2018
Semen AMACR protein as a novel method for detecting prostate cancer
Tyler Etheridge, Jane Straus, Mark A Ritter, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
July 17, 2003
Rectal dose sparing with a balloon catheter and ultrasound localization in conformal radiation therapy for prostate cancer
Rakesh R Patel, Nigel Orton, Wolfgang A Tomé, et al.
Page
of 4